Get Free Trial
News & Analysis
On The Fly
About The Fly
Instant updates and real-time market news.
MYnd Analytics 1.675M share Secondary priced at $5.25
Maxim and Aegis acted as joint book running managers for the offering.
MYnd Analytics initiated with a Buy at Maxim
Maxim analyst Lauren Chung initiated MYnd Analytics with a Buy rating and $18 price target, saying that given the need for a test to guide the optimization of depression therapy that 'just modest market penetration" could translate into substantial revenues.
TODAY'S FREE FLY STORIES